Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer

BACKGROUND: The purpose of this study was to assess the efficacy of Bacillus Calmette-Guerin (BCG) therapy after a second transurethral resection (TUR) in new onset high-grade T1 bladder cancer. METHODS: From January 2008 to September 2013, 207 patients with new onset high-grade T1 bladder cancer af...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Urol
Main Authors: Iida, Keitaro, Naiki, Taku, Kawai, Noriyasu, Etani, Toshiki, Ando, Ryosuke, Ikegami, Yosuke, Okamura, Takehiko, Kubota, Hiroki, Okada, Atsushi, Kohri, Kenjiro, Yasui, Takahiro
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4769574/
https://ncbi.nlm.nih.gov/pubmed/26920373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0126-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares